You are here

  • Home
  • Archive
  • Volume 24, Issue 3
  • Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer

Article metrics

Article menu
Download PDFPDF
Uterine Cancer
Phase I Clinical Trial of the Mammalian Target of Rapamycin Inhibitor Everolimus in Combination With Oral Topotecan for Recurrent and Advanced Endometrial Cancer

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019400
Mar 20191800
Apr 20191300
May 20193200
Jun 20191800
Jul 20193701
Aug 20197300
Sep 20194603
Oct 20193000
Nov 20193203
Dec 20192200
Jan 20201801
Feb 20201800
Mar 20201800
Apr 20203200
May 20201300
Jun 20201600
Jul 20202000
Aug 20202400
Sep 20201800
Oct 20202001
Nov 2020700
Dec 20201000
Jan 20212000
Feb 20211601
Mar 20211402
Apr 20211400
May 2021200
Jun 2021100
Aug 2021001
Sep 2021001
Oct 20212801
Nov 2021802
Dec 20212001
Jan 20222001
Feb 2022700
Mar 20221400
Apr 20222901
May 20225000
Jun 20223800
Jul 20222401
Aug 20225006
Sep 20225200
Oct 20228503
Nov 20222402
Dec 20225600
Jan 20234401
Feb 20239500
Mar 20233300
Apr 2023600
May 2023600
Jun 2023800
Jul 20232900
Aug 20231600
Sep 20232001
Oct 20234301
Nov 20234601
Dec 20235002
Jan 20241800
Feb 20242000
Mar 202412202
Apr 20244400
Total1711040